Delivery Order SPE2DB25D9302-SPE2DB25FLNZG

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $8,331.72 order is for the supply of NEXPLANON 68 MG IMPLANTS, a prescription contraceptive device, with a period of performance through March 2025.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract award is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contract awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its ability to provide a diverse array of pharmaceutical products to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.